Bank of Nova Scotia’s NEVRO CORP. NVRO Stock Holding History

Bank of Nova Scotia’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-61,000	Closed	-$4.21M	–	1017
2017 Q4	$4.21M	Buy	+61,000	New	+$4.88M	0.02%	432

Other funds holding NVRO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Bank of Nova Scotia's NVRO Position: Q1 2018 in Review

Bank of Nova Scotia sold out of NEVRO CORP. (NVRO) in Q1 2018, closing a stake of 61,000 shares — an estimated $4.21M sold.

Bank of Nova Scotia first reported a position in NVRO in Q4 2017 and held it in 1 quarter. The position peaked at $4.21M in Q4 2017. 197 funds tracked by Wall St. Rank hold NVRO as of Q1 2018.

Bank of Nova Scotia reported no remaining NEVRO CORP. position as of Q1 2018 after selling out during the quarter.
Bank of Nova Scotia sold 61,000 NEVRO CORP. shares in Q1 2018, an estimated $4.21M.
Bank of Nova Scotia first reported a position in NEVRO CORP. in Q4 2017 and held it in 1 quarter.
Bank of Nova Scotia's NEVRO CORP. position peaked at $4.21M in Q4 2017.
197 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2018.

Based on Bank of Nova Scotia's 13F filing for Q1 2018, filed 15 May 2018.